Vicore to kickstart Phase IIb IPF trial for buloxibutid
Vicore Pharma will initiate the Phase IIb trial by the end of H1 2024.
Source: yahoo.com
Fast, Ad-Free News Updates
Stay updated with breaking news from Both Ofev. Real-time updates on events, politics, business and more.